Other Issues

Acetaminophen was chosen for review by OEHHA in part because the Prop 65 regulation emphasizes chemicals with “widespread exposure.” The Carcinogen Identification Committee will review the information on acetaminophen and cancer to determine whether acetaminophen should be listed as a carcinogen under Proposition 65.

The observational Internet survey results pre-published in the American Journal of Gastroenterology reporting an association between use of proton-pump inhibitor (PPI) medicines and self-reported positive tests for COVID-19 among people taking PPIs do not prove cause-and-effect.

The 2019 results from the NIDA and University of Michigan’s annual drug abuse survey, Monitoring the Future, show that the number of teens using OTC cough medicine containing DXM to get high decreased slightly.

CHPA today applauds the U.S. Food and Drug Administration for enforcing existing provisions in the Federal Food, Drug, and Cosmetic Act by sending warning letters to 15 companies illegally marketing cannabidiol products.

Michigan Governor Gretchen Whitmer today signed HB 4412, legislation to combat teen abuse of OTC medicines containing the cough suppressant dextromethorphan (DXM).

Today CHPA submitted a citizen petition to the U.S. Food and Drug Administration urging the agency to exercise its existing statutory authority to swiftly issue regulations that establish a clear pathway for manufacturers to lawfully market cannabidiol in dietary supplements. 

Through several CHPA member company donations, 144 U.S. schools of pharmacy received over 100 different OTC medicines, medical devices, and dietary supplements to educate and prepare future pharmacists.